Q&A with Patti Columbe: A glimpse into her journey with Vertex’s manufactured islets
Breakthrough T1D had the pleasure of speaking with Patti Columbe, a participant in Vertex’s pivotal trial for the manufactured islet therapy zimislecel (formerly VX-880). Patti has been living with type 1 diabetes (T1D) for nearly 39 years. This is one of the most exciting T1D trials in terms of getting us closer to cures for […]
Fundraise Your Way with Breakthrough T1D
With Breakthrough T1D Your Way, you use your time, talent, and creativity to fuel type 1 diabetes research. You name it, we support you!
Ten years of impact: A closer look at Breakthrough T1D’s training awards
To drive our mission forward, Breakthrough T1D financially supports type 1 diabetes (T1D) research through training awards and grants to academic scientists or clinicians, investments in promising companies, conference support, and more. Here, we take a deeper dive specifically into our training awards offered to early-stage researchers to understand the impact and outcomes that these […]
Tzield receives voucher for expedited review in stage 3 T1D
This past week, the FDA and Sanofi, the maker of Tzield, made an important announcement. Tzield, the first disease-modifying therapy approved for delaying onset of stage 3 type 1 diabetes (T1D) in people with stage 2 T1D, has been accepted into the FDA Commissioner’s National Priority Voucher (CNPV) program for people with stage 3 T1D. […]
Civica long-acting insulin available on January 1, 2026
Nearly 3 years ago, Breakthrough T1D joined forces with Civica Rx, a non-profit pharmaceutical company, to manufacture and distribute low-cost insulins. Starting on January 1, 2026, the first of those insulins, insulin glargine-yfgn (a long-acting insulin interchangeable with Lantus®), will be available for purchase. 5 Pens, No More Than $55 – for anyone While we […]
Two truths and a lie: Separate T1D facts from fiction
There are a lot of commonly believed myths about type 1 diabetes (T1D). Play our game to separate fact from fiction.
Celebrating Halloween with type 1 diabetes
Tips for families on juggling type 1 diabetes with the super sweet fun of Halloween.
The Nobel Prize goes to… Immunologists (with a Breakthrough T1D connection!)
The Nobel Prize in Physiology or Medicine went to three immunologists, including one, Fred Ramsdell, who founded a T1D Fund company.
Managing cold and flu with type 1 diabetes
When living with type 1 diabetes (T1D), illnesses like cold and flu require extra attention. Get tips on managing T1D when sick.
The inside scoop on the CATT1 clinical trial
Learn about the people making the CATT1 clinical trial happen, the science behind cadisegliatin for type 1 diabetes, and how to get involved.
